Tokyo Tape
Sign in
← H.U. Group Holdings

Quarterly report · Q3

4544.TEDINET S100Q5GN
Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
MetricValuePeriodScopeSource row
Revenue¥201.0bn2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥272.9bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥197.9bn2021-04-01 → 2021-12-31Cons.Net sales
Operating income¥23.6bn2022-04-01 → 2022-12-31Cons.Operating income
Operating income¥36.2bn2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income¥23.2bn2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥47.4bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥35.5bn2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥25.8bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥33.7bn2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥18.8bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥29.6bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥25.5bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥18.8bn2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥25.5bn2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥280.3bnat 2022-12-31Cons.Assets
Total assets¥286.6bnat 2022-03-31Cons.Assets
Total assets¥277.0bnat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥127.2bnat 2022-12-31Cons.Liabilities
Total liabilities¥146.4bnat 2022-03-31Cons.Liabilities
Net assets / equity¥153.2bnat 2022-12-31Cons.Net assets
Net assets / equity¥140.2bnat 2022-03-31Cons.Net assets
Net assets / equity¥133.6bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥30.5bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥46.5bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥30.5bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥46.5bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥46.2bnat 2021-12-31Cons.Cash and cash equivalents
Cash & equivalents¥43.0bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥19.2bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥55.2bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥38.4bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥24.9bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥30.9bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥19.2bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥10.9bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥21.7bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥16.1bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥330.262022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥56.842022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥519.552021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥447.682021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥105.452021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥330.222022-04-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥519.422021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥447.552021-04-01 → 2021-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio54.6%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio48.9%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio48.2%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥6.2bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥6.2bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥3.3bn
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥124.9bn
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥124.7bn
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥212m
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥2.7bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥61.6bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥55.6bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥5.9bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥23.4bn
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentrevenue2022-04-01 → 2022-12-31¥20.7bn
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentrevenue external2022-04-01 → 2022-12-31¥20.6bn
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥15m
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentsegment profit2022-04-01 → 2022-12-31¥825m
—segment totalrevenue2022-04-01 → 2022-12-31¥207.1bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥201.0bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥6.2bn
—segment totalsegment profit2022-04-01 → 2022-12-31¥26.9bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-12-31−¥7.2bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-12-31−¥7.2bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-12-31−¥775m
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue2021-04-01 → 2021-12-31¥131.2bn
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue external2021-04-01 → 2021-12-31¥131.0bn
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥216m
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentsegment profit2021-04-01 → 2021-12-31¥17.7bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue2021-04-01 → 2021-12-31¥52.1bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue external2021-04-01 → 2021-12-31¥45.2bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥7.0bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentsegment profit2021-04-01 → 2021-12-31¥17.8bn
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentrevenue2021-04-01 → 2021-12-31¥21.8bn
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentrevenue external2021-04-01 → 2021-12-31¥21.7bn
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥15m
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentsegment profit2021-04-01 → 2021-12-31¥1.4bn
—segment totalrevenue2021-04-01 → 2021-12-31¥205.1bn
—segment totalrevenue external2021-04-01 → 2021-12-31¥197.9bn
—segment totalrevenue intersegment2021-04-01 → 2021-12-31¥7.2bn
—segment totalsegment profit2021-04-01 → 2021-12-31¥36.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 479
ItemContextValueUnit
Non operating incomePrior1YTDDuration1420000000JPY
Non operating incomeCurrentYTDDuration1299000000JPY
Interest expenses noePrior1YTDDuration293000000JPY
Interest expenses noeCurrentYTDDuration279000000JPY
Equity in losses of affiliates noePrior1YTDDuration1407000000JPY
Equity in losses of affiliates noeCurrentYTDDuration1315000000JPY
Other noePrior1YTDDuration406000000JPY
Other noeCurrentYTDDuration179000000JPY
Non operating expensesPrior1YTDDuration2107000000JPY
Non operating expensesCurrentYTDDuration1774000000JPY
Ordinary incomePrior1YTDDuration35484000000JPY
Ordinary incomeCurrentYTDDuration23175000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration80000000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration2622000000JPY
Gain on reversal of subscription rights to shares eiPrior1YTDDuration40000000JPY
Gain on reversal of subscription rights to shares eiCurrentYTDDuration－JPY
Gain on step acquisitions eiPrior1YTDDuration－JPY
Gain on step acquisitions eiCurrentYTDDuration758000000JPY
Other eiPrior1YTDDuration48000000JPY
Other eiCurrentYTDDuration26000000JPY
Extraordinary incomePrior1YTDDuration169000000JPY
Extraordinary incomeCurrentYTDDuration3407000000JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration67000000JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration60000000JPY
Loss on valuation of other investments elPrior1YTDDuration685000000JPY
Loss on valuation of other investments elCurrentYTDDuration217000000JPY
Other elPrior1YTDDuration1184000000JPY
Other elCurrentYTDDuration519000000JPY
Extraordinary lossPrior1YTDDuration1938000000JPY
Extraordinary lossCurrentYTDDuration796000000JPY
Income before income taxesPrior1YTDDuration33716000000JPY
Income before income taxesCurrentYTDDuration25786000000JPY
Income taxes currentPrior1YTDDuration6843000000JPY
Income taxes currentCurrentYTDDuration3934000000JPY
Income taxes deferredPrior1YTDDuration1391000000JPY
Income taxes deferredCurrentYTDDuration3062000000JPY
Income taxesPrior1YTDDuration8234000000JPY
Income taxesCurrentYTDDuration6997000000JPY
Profit lossPrior1YTDDuration25481000000JPY
Profit lossCurrentYTDDuration18789000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration-37000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration－JPY
Profit loss attributable to owners of parentPrior1YTDDuration25518000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration18789000000JPY
Profit lossPrior1YTDDuration25481000000JPY
Profit lossCurrentYTDDuration18789000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration1511000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration-1301000000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration1260000000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration2468000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass